Clinical Trials at UPMC Hillman Cancer Center at Butler Health System
As of August 2026, 12 paid clinical trials are recruiting at UPMC Hillman Cancer Center at Butler Health System in Butler, Pennsylvania. Active studies at this site cover conditions such as Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma and Stage IV Lung Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
12 clinical trials at UPMC Hillman Cancer Center at Butler Health System
·Clear filters·Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Distance-Based Exercise to Preserve Function and Prevent Disability
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Common conditions studied in Butler
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (2 active studies)
- Stage IV Lung Cancer AJCC v8 (2 active studies)
- APOL1-Mediated Kidney Disease (1 active study)
- Anal Cancer (1 active study)
- Anatomic Stage I Breast Cancer AJCC v8 (1 active study)
Leading research sponsors in Butler
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- First Institute of All Medicines
- AstraZeneca
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Butler?
There are approximately 19 recruiting clinical trials in Butler, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Butler pay participants?
Most recruiting trials in Butler compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Butler?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Butler?
The most common conditions under active study in Butler include Anatomic Stage II Breast Cancer AJCC v8 (2), Recurrent Lung Non-Small Cell Carcinoma (2), Stage IV Lung Cancer AJCC v8 (2), APOL1-Mediated Kidney Disease (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Butler?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Butler on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Butler?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Butler?
Recruiting research sites in Butler include UPMC Hillman Cancer Center at Butler Health System, Tesla BioHealing Medical Center in Butler-PA, Butler Memorial Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Butler right now?
The largest active categories in Butler are Cancer & tumors (11), Diabetes & metabolic (1), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.